Inventor · disambiguated record
Jason P. Burke
Also filed as: BURKE JASON · BURKE JASON P
22 granted patents·5 pending applications·149 citations·filing 2007–2025
95Inventor score
Top patents by PatentIndex Score
27 records- 0196US11603365B2Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2020·Granted Mar 14, 2023·4 cites·30 claims
- 0296US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0395US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0495US10954243B2Substituted heterocyclic inhibitors of PTPN11NAVIRE PHARMA INC·Filed 2019·Granted Mar 23, 2021·35 cites·18 claims
- 0595US10899740B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·8 cites·15 claims
- 0694US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0794US10150753B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2016·Granted Dec 11, 2018·7 cites·15 claims
- 0893US11713313B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Aug 1, 2023·3 cites·12 claims
- 0993US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 1092US10738043B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2018·Granted Aug 11, 2020·6 cites·12 claims
- 1192US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 1291US10125128B2GLS1 inhibitors for treating diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Nov 13, 2018·13 cites·21 claims
- 1389US8148391B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitorsAHMED GULZAR·Filed 2007·Granted Apr 3, 2012·17 cites·8 claims
- 1488US12172992B2Pyrimidines for degrading Bruton's tyrosine kinaseABBVIE INC·Filed 2023·Granted Dec 24, 2024·2 cites·3 claims
- 1586US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1685US8552186B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitorsAHMED GULZAR·Filed 2012·Granted Oct 8, 2013·10 cites·26 claims
- 1784US12252480B2Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2023·Granted Mar 18, 2025·0 cites·10 claims
- 1875US2025250253A1Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamideUNIV TEXAS·Filed 2025·Application pending·0 cites
- 1969US2025304568A1Pyrimidines for degrading bruton's tyrosine kinaseABBVIE INC·Filed 2024·Application pending·0 cites
- 2065US10005728B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2014·Granted Jun 26, 2018·0 cites·25 claims
- 2161US11932643B2Substituted heterocyclic inhibitors of PTPN11NAVIRE PHARMA INC·Filed 2021·Granted Mar 19, 2024·0 cites·21 claims
- 2261US10954193B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2018·Granted Mar 23, 2021·0 cites·19 claims
- 2352US9365621B2Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivationUNIV CALIFORNIA·Filed 2013·Granted Jun 14, 2016·0 cites·3 claims
- 2448US9573977B2Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivationUNIV CALIFORNIA·Filed 2016·Granted Feb 21, 2017·0 cites·7 claims
- 2540US2016002204A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 2636US9949965B2Tricyclic indole Mcl-1 inhibitors and uses thereofUNIV VANDERBILT·Filed 2015·Granted Apr 24, 2018·0 cites·19 claims
- 2735US2016002248A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason P. Burke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →